Association between UHMWPE particle-induced inflammatory osteoclastogenesis and expression of RANKL, VEGF, and Flt-1 in vivo

被引:85
作者
Ren, Wei Ping
Markel, David C.
Zhang, Renwen
Peng, Xin
Wu, Bin
Monica, Hawkins
Wooley, Paul H.
机构
[1] Wayne State Univ, Sch Med, Univ Ctr Hlth 7C, Dept Orthoped Surg, Detroit, MI 48201 USA
[2] Stryker Co, Rutherford, NJ 07070 USA
关键词
VEGF; RANKL; Flt-1; wear debris; osteoclastogenesis;
D O I
10.1016/j.biomaterials.2006.04.004
中图分类号
R318 [生物医学工程];
学科分类号
0831 [生物医学工程];
摘要
Wear debris-induced vascularized granulomatous periprosthetic tissue may augment the progress of prosthetic loosening, a major clinical problem after total joint replacement. The purpose of this study is to investigate the association of ultra-high-molecular-weight polyethylene (UHMWPE) particle-induced inflammatory osteoclastogenesis and expression of RANK/RANKL and VEGF/VEGF receptors (Flt-1 and Flk-1) using a mouse osteolysis model. UHMWPE particles were introduced into established air pouches on BALB/c mice, followed by implantation of calvaria bone from syngeneic littermates. Mice were injected with either recombinant VEGF or VEGF inhibitor (VEGF R2/F-c Chimera). Mice without drug treatment, as well as mice injected with saline alone were included. Each group contains 10 mice. Pouch tissues were harvested 2 weeks after bone implantation for histological and molecular analysis. UHMWPE stimulation significantly increased VEGF gene expression, and exerted a lower enhancement effect on the gene expression of Flt-1 and Flk-1. UHMWPE-stimulated VEGF production was markedly reduced by VEGF inhibitor treatment. Immunofluorescent staining indicated that pouch tissue macrophages were the main source of both VEGF and Flt-1 production. A positive association was observed between tissue inflammation and the levels of VEGF and Flt-1 gene transcripts. Both RANK and RANKL gene transcripts were significantly increased by UHMWPE stimulation, which was subsequently reduced by VEGF inhibitor treatment (p < 0.05). VEGF treatment increased TRAP(+) cells in pouches either with or without UHMWPE particle stimulation, and VEGF inhibitor treatment caused a significant reduction in the number of TRAP(+) cells in UHMWPE-containing pouches. This study suggests that VEGF has a role in the regulation of RANK/RANKL-mediated osteoclastogenesis, and warrant future investigations to elucidate the role of VEGF signaling in the pathogenesis of prosthetic loosening. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5161 / 5169
页数:9
相关论文
共 38 条
[1]
NEOVASCULARIZATION AND THE INDUCTION OF CELL-ADHESION MOLECULES IN RESPONSE TO DEGRADATION PRODUCTS FROM ORTHOPEDIC IMPLANTS [J].
ALSAFFAR, N ;
MAH, JTL ;
KADOYA, Y ;
REVELL, PA .
ANNALS OF THE RHEUMATIC DISEASES, 1995, 54 (03) :201-208
[2]
Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1 [J].
Barleon, B ;
Sozzani, S ;
Zhou, D ;
Weich, HA ;
Mantovani, A ;
Marme, D .
BLOOD, 1996, 87 (08) :3336-3343
[3]
Blockade of vascular endothelial growth factor receptor I (VEGF-RI), but not VEGF-RII, suppresses joint destruction in the K/BxN model of rheumatoid arthritis [J].
De Bandt, M ;
Ben Mahdi, MH ;
Ollivier, V ;
Grossin, M ;
Dupuis, M ;
Gaudry, M ;
Bohlen, P ;
Lipson, KE ;
Rice, A ;
Wu, Y ;
Gougerot-Pocidalo, MA ;
Pasquier, C .
JOURNAL OF IMMUNOLOGY, 2003, 171 (09) :4853-4859
[4]
RANK is essential for osteoclast and lymph node development [J].
Dougall, WC ;
Glaccum, M ;
Charrier, K ;
Rohrbach, K ;
Brasel, K ;
De Smedt, T ;
Daro, E ;
Smith, J ;
Tometsko, ME ;
Maliszewski, CR ;
Armstrong, A ;
Shen, V ;
Bain, S ;
Cosman, D ;
Anderson, D ;
Morrissey, PJ ;
Peschon, JJ ;
Schuh, J .
GENES & DEVELOPMENT, 1999, 13 (18) :2412-2424
[5]
Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones [J].
Engsig, MT ;
Chen, QJ ;
Vu, TH ;
Pedersen, AC ;
Therkidsen, B ;
Lund, LR ;
Henriksen, K ;
Lenhard, T ;
Foged, NT ;
Werb, Z ;
Delaisse, JM .
JOURNAL OF CELL BIOLOGY, 2000, 151 (04) :879-889
[6]
VASCULAR-PERMEABILITY FACTOR ENDOTHELIAL GROWTH-FACTOR (VPF/VEGF) - ACCUMULATION AND EXPRESSION IN HUMAN SYNOVIAL-FLUIDS AND RHEUMATOID SYNOVIAL TISSUE [J].
FAVA, RA ;
OLSEN, NJ ;
SPENCERGREEN, G ;
YEO, KT ;
YEO, TK ;
BERSE, B ;
JACKMAN, RW ;
SENGER, DR ;
DVORAK, HF ;
BROWN, LF .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (01) :341-346
[7]
Expression and function of the vascular endothelial growth factor receptor FLT-1 in human eosinophils [J].
Feistritzer, C ;
Kaneider, NC ;
Sturn, DH ;
Mosheimer, BA ;
Kädhler, CM ;
Wiedermann, CJ .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2004, 30 (05) :729-735
[8]
The biology of vascular endothelial growth factor [J].
Ferrara, N ;
DavisSmyth, T .
ENDOCRINE REVIEWS, 1997, 18 (01) :4-25
[9]
Ferrer CJ., 2002, AN MED INTERN, V19, P385
[10]
The molecular perspective: VEGF and angiogenesis [J].
Goodsell, DS .
ONCOLOGIST, 2002, 7 (06) :569-570